DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,447,266 | +15.2% | 301,101 | +0.7% | 0.01% | +20.0% |
| Q2 2023 | $3,861,309 | +30.4% | 298,863 | -1.0% | 0.01% | +25.0% |
| Q1 2023 | $2,961,390 | -4.0% | 301,874 | +4.1% | 0.00% | -20.0% |
| Q4 2022 | $3,084,562 | +1.7% | 289,903 | -0.2% | 0.01% | 0.0% |
| Q3 2022 | $3,033,000 | -20.5% | 290,504 | -4.1% | 0.01% | -16.7% |
| Q2 2022 | $3,813,000 | +12.5% | 302,865 | -3.1% | 0.01% | +20.0% |
| Q1 2022 | $3,389,000 | -26.4% | 312,634 | -4.4% | 0.01% | -16.7% |
| Q4 2021 | $4,603,000 | -23.5% | 327,134 | +4.5% | 0.01% | -33.3% |
| Q3 2021 | $6,015,000 | +232.9% | 313,112 | +70.7% | 0.01% | +200.0% |
| Q2 2021 | $1,807,000 | +0.5% | 183,448 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $1,798,000 | – | 182,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |